News | October 19, 2011

Cellagon aurum- Daily Nutrition Formulation Now Enhanced With PromOat Beta Glucan

German health drink company Hans-Günter Berner GmbH & Co. KG has enhanced its Cellagon aurum brand with the inclusion of PromOat, the all-natural oat beta glucan ingredient from Swedish company Biovelop AB.

First launched in 1986, Cellagon aurum is a perfectly-balanced liquid formulation, made from more than 70 carefully-selected ingredients, including fruits, herbs, vegetables, oils, fungi and algae. The ingredients work synergistically to help provide consumers with their daily intake of healthy nutrition, and the outstanding quality of Cellagon aurum is tested and verified by independent laboratories and university studies.

The addition of PromOat, a naturally-separated, oat beta glucan-rich soluble fibre ingredient produced from Swedish oats, further boosts Cellagon aurum's already-strong health credentials by enabling consumers to enjoy the widely-recognised and scientifically-substantiated health benefits of oats. In particular, PromOat beta glucan can naturally stabilize and lower blood cholesterol levels, slow the release of sugar into the bloodstream and support healthy intestinal flora.

PromOat makes a valuable contribution to Cellagon's comprehensive range of bioactive ingredients, helping to create products that are both nutritious and delicious.

The new Cellagon aurum containing PromOat beta glucan is available from Cellagon retailers or online at www.cellagon.de

For further information on PromOat, please visit www.promoat.com

About Biovelop
Biovelop is the world's leading producer of oat beta glucan and other specialty ingredients from oats. Using its patented, chemical-free technology for the fractionation of grains, Biovelop produces natural, healthy ingredients for cosmetics and personal care products under the brand name Avenacare, and for food, beverage and nutritional supplements under the brand name PromOat. The company is headquartered in Kimstad, Sweden and its products are sold globally via an extensive network of distribution companies.

SOURCE: Biovelop AB